You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 7,371,928


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,371,928
Title:Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter
Abstract: Provided are a seed-specific expression promoter derived from sesame microsomal oleic acid desaturase (Si-FAD2) gene, an intron for expression enhancement, a seed-specific expression vector including the promoter and/or the intron, and a transgenic plant transformed with the seed-specific expression vector. Therefore, a useful product can be produced in a seed-specific manner or a common product in a seed can be functionally modified. Also, the promoter can be used together with the intron for expression enhancement, thereby increasing the expression level of an inserted gene in a seed. Therefore, it is very useful in development of a transgenic plant which induces large-scale expression of a foreign gene in a seed-specific manner.
Inventor(s): Suh; Mi-Chung (Seoul, KR), Kim; Mi-Jung (Seoul, KR), Kim; Hee-Ja (Seoul, KR), Chung; Chung-Han (Busan, KR), Pyee; Jae-Ho (Gunpo, KR), Hyung; Nam-In (Cheonan, KR)
Assignee: Korea Chungang Educational Foundation (Seoul, KR)
Application Number:10/534,128
Patent Claims:1. An isolated seed-specific promoter comprising SEQ ID NO: 3 or an active fragment thereof.

2. The seed-specific expression promoter of claim 1, which comprises the nucleotide sequence as set forth in SEQ ID NO: 3.

3. A seed-specific expression vector comprising the promoter of claim 1.

4. The seed-specific expression vector of claim 3, which is constructed by inserting the promoter upstream of a foreign gene of a binary vector.

5. The seed-specific expression vector of claim 4, wherein said foreign gene encodes a FAD2.

6. The seed-specific expression vector of claim 3, which is constructed by inserting the promoter upstream of a foreign gene of a transient expression vector.

7. The seed-specific expression vector of claim 6, wherein said foreign gene encodes a FAD2.

8. A transgenic plant transformed with the seed-specific expression vector of claim 3.

9. A method for expressing a foreign gene in a transgenic plant transformed with the seed-specific expression vector of claim 3.

10. The seed-specific expression vector of claim 3, which further comprises an intron for enhancement of gene expression comprising nucleotides 149 to 1722 of SEQ ID NO. 1.

Details for Patent 7,371,928

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2022-11-11
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2022-11-11
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2022-11-11
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.